Pioneering cellular medicines for women’s health

We’re developing off-the-shelf cell therapies for high-impact women’s diseases, with lead programs in ovarian cancer, triple negative breast cancer and endometriosis.

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.

Learn more about us

Some of our partners

Latest news

Miracle Elixirs

By Christine Filippis / April 4, 2019
A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”- a...
Read More

It’s time for a worldwide moratorium on editing human embryos

By Christine Filippis / April 2, 2019
by Alan Trounson Hear Alan Trounson discuss the issue Saturday 6 April at 12 noon on ABC Radio National’s The...
Read More

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

By Christine Filippis / April 2, 2019
https://health.ucsd.edu/news/releases/Pages/2019-04-01-UC-San-Diego-Health-Treats-Cancer-Patient-with-Stem-Cell-Derived-Natural-Killer-Cells.aspx UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells Fate Therapeutics, in collaboration with...
Read More